IJ Pharmaceutical Research
Crossref
1. Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS)
- Roozbeh Heidarzadehpilehrood
- Maryam Pirhoushiaran
2. Plasma miRNAs in polycystic ovary syndrome drive endometrial cancer progression: insights into molecular pathways and therapeutic targets
- Xuedan Lai
- Ling Wu
- Peihong Lin
- Lijiao You
- Jianwen Ye
3. Upregulated PCAT-1 predicts poor prognosis and reduced immune cell infiltration in head and neck squamous cell carcinoma through the miR-145-5p / FSCN-1 axis
- Maryam Pirhoushiaran
- Roozbeh Heidarzadehpilehrood
- Mahnoosh Mokhtarinejad
- Sara Hesami
- Nima Rezaei
- Abbas Shakoori Farahani
4. CAPN2 correlates with insulin resistance states in PCOS as evidenced by multi-dataset analysis
- Xi Luo
- Yunhua Dong
- Haishan Zheng
- Xiaoting Zhou
- Lujuan Rong
- Xiaoping Liu
- Yun Bai
- Yunxiu Li
- Ze Wu
5. Whole transcriptome analysis and construction of gene regulatory networks of granulosa cells from patients with polycystic ovary syndrome (PCOS)
- Yuan Yuan
- Daiterigele
- Qian Zhang
- Chen Du
6. Polycystic Ovary Syndrome and Ferroptosis: Following Ariadne’s Thread
- Styliani Geronikolou
- Athanasia Pavlopoulou
- Ioannis Koutelekos
- Dimitrios Kalogirou
- Flora Bacopoulou
- Dennis V. Cokkinos
7. Upregulated long non-coding RNAs TMPO-AS1, DDX11-AS1, and POLE gene expression predict poor prognosis in head and neck squamous cell carcinoma (HNSCC)
- Mahnoosh Mokhtarinejad
- Maryam Pirhoushiaran
- Roozbeh Heidarzadehpilehrood
- Sara Hesami
- Farid Azmoudeh-Ardalan
- Abbas Shakoori Farahani
8. A Cross-Sectional Exploratory Study of Rat Sarcoid (Ras) Activation in Women with and Without Polycystic Ovary Syndrome
- Sara Anjum Niinuma
- Haniya Habib
- Ashleigh Suzu-Nishio Takemoto
- Priya Das
- Thozhukat Sathyapalan
- Stephen L. Atkin
- Alexandra E. Butler